Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial
This study may provide conclusive evidence about the life-prolonging potential of lithium carbonate in a genetic ALS subgroup.Trial registrationEudraCT number2020-000579-19. Registered on 29 March 2021. (Source: Trials)
Source: Trials - December 5, 2022 Category: Research Source Type: clinical trials

Effect of Lithium Therapy on Long COVID Symptoms
Condition:   Long COVID Interventions:   Drug: Lithium;   Drug: Placebo Sponsor:   University at Buffalo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2022 Category: Research Source Type: clinical trials